Company Overview
Company Name
Immune-Onc Therapeutics
Address
795 San Antonio Rd, Palo Alto, CA, 94303, United States
Website
immune-onc.comPhone
(650) 460-8898Approx. Annual Revenue
$7.2M
Employees
40
Established
2016
About Immune-Onc Therapeutics
Immune-Onc is a clinical-stage biopharmaceutical company based in Palo Alto, California, that is advancing novel therapies targeting myeloid cells. The company's research team is exploring myeloid cell surface proteins as potential therapeutic targets to transform treatment approaches for blood cancers, solid tumors, autoimmune, and inflammatory diseases.
Business Profile
Read from the Immune-Onc Therapeutics website on Oct 15, 2026. Hover an item to see the exact wording it came from.
About the website
- Website quality (AI-assessed)
- 7/10 · Current copyright notice; Clear navigation and content
- Footer copyright year
- 2024
Biotech & Life Sciences Companies near Palo Alto, CA
- Kodiak Scienceskodiak.com
- Palo Alto Veterans Institute for Researchpavir.org
- Guardant Healthguardanthealth.com
- Vaxcytevaxcyte.com
- Santa Cruz Biotechnologyscbt.com
- Alto Neurosciencealtoneuroscience.com
- AN2 Therapeuticsan2therapeutics.com
- Orca Bioorcabio.com
- Lytenlyten.com
- PROCEPT BioRoboticsprocept-biorobotics.com
Frequently Asked Questions about Immune-Onc Therapeutics
Categories
Technologies Used
'%20fill='%23000000'%3e%3cg%20id='icons'%20transform='translate(56.000000,%20160.000000)'%3e%3cpath%20d='M102.8695,7446.25504%20C101.3625,7444.73916%2098.9185,7444.73916%2097.4115,7446.25504%20L91.2705,7452.43224%20C90.8935,7452.81045%2090.8935,7453.42505%2091.2705,7453.80428%20C91.6475,7454.1835%2092.2585,7454.1835%2092.6355,7453.80428%20L98.7755,7447.62809%20C99.5285,7446.86964%20100.7515,7446.86964%20101.5045,7447.62809%20C102.2585,7448.38552%20102.2585,7449.61473%20101.5045,7450.37317%20L95.4825,7456.43066%20C96.2355,7457.1881%2097.4575,7457.1881%2098.2115,7456.43066%20L102.8695,7451.74521%20C104.3765,7450.22933%20104.3765,7447.77092%20102.8695,7446.25504%20M100.8225,7448.31411%20C100.4455,7447.93488%2099.8345,7447.93488%2099.4575,7448.31411%20L93.3175,7454.49029%20C92.5635,7455.24874%2091.3415,7455.24874%2090.5885,7454.49029%20C90.2115,7454.11107%2089.6005,7454.11107%2089.2235,7454.49029%20C88.8465,7454.86952%2088.8465,7455.48412%2089.2235,7455.86233%20C90.7305,7457.37922%2093.1745,7457.37922%2094.6825,7455.86233%20L100.8225,7449.68615%20C101.1995,7449.30793%20101.1995,7448.69232%20100.8225,7448.31411%20M98.7755,7442.13691%20C97.2685,7440.62103%2094.8245,7440.62103%2093.3175,7442.13691%20L87.1765,7448.31411%20C86.8005,7448.69232%2086.8005,7449.30793%2087.1765,7449.68615%20C87.5535,7450.06537%2088.1645,7450.06537%2088.5415,7449.68615%20L94.6825,7443.50996%20C95.4355,7442.75151%2096.6575,7442.75151%2097.4105,7443.50996%20C97.7875,7443.88918%2098.3985,7443.88918%2098.7755,7443.50996%20C99.1525,7443.13073%2099.1525,7442.51613%2098.7755,7442.13691%20M96.7285,7444.19598%20C96.3515,7443.81675%2095.7405,7443.81675%2095.3645,7444.19598%20L89.2235,7450.37317%20C88.4695,7451.13061%2087.2485,7451.13061%2086.4945,7450.37317%20C85.7405,7449.61473%2085.7405,7448.38552%2086.4945,7447.62708%20L92.5175,7441.56959%20C91.7635,7440.81114%2090.5415,7440.81114%2089.7875,7441.56959%20L85.1295,7446.25504%20C83.6235,7447.77092%2083.6235,7450.22933%2085.1295,7451.74521%20C86.6375,7453.2621%2089.0805,7453.2621%2090.5885,7451.74521%20L96.7285,7445.56902%20C97.1055,7445.1898%2097.1055,7444.5752%2096.7285,7444.19598'%20id='squarespace-[%23132]'%3e%3c/path%3e%3c/g%3e%3c/g%3e%3c/g%3e%3c/svg%3e)
%20--%3e%3csvg%20version='1.1'%20id='st_x5F_cc_x5F_app_x5F_RGB.svg'%20xmlns='http://www.w3.org/2000/svg'%20xmlns:xlink='http://www.w3.org/1999/xlink'%20x='0px'%20y='0px'%20viewBox='0%200%20240.0004%20234.0004'%20style='enable-background:new%200%200%20240.0004%20234.0004;'%20xml:space='preserve'%3e%3cstyle%20type='text/css'%3e%20.st0{fill:url(%23SVGID_1_);}%20.st1{fill:%23FFFFFF;}%20%3c/style%3e%3clinearGradient%20id='SVGID_1_'%20gradientUnits='userSpaceOnUse'%20x1='119.9997'%20y1='234.0002'%20x2='119.9997'%20y2='0.0002'%3e%3cstop%20offset='0'%20style='stop-color:%23201F21'/%3e%3cstop%20offset='1'%20style='stop-color:%23313131'/%3e%3c/linearGradient%3e%3crect%20x='-0.0003'%20y='0.0002'%20class='st0'%20width='240'%20height='234'/%3e%3cg%3e%3cpath%20class='st1'%20d='M132.24969,97.95853c-5.60328,18.77988-10.28088,36.91208-15.88416,54.63138%20c-3.18081,9.99579-6.66385,19.53729-11.05544,25.59485c-4.84678,6.81497-13.93402,13.32771-24.83743,13.32771%20c-7.72443,0-15.29683-3.63509-15.29683-11.66174c0-4.99789,5.14901-9.69264,9.23837-9.69264%20c2.42339,0,3.63508,1.36282,4.24046,2.42339c3.7862,6.81497,7.42128,10.75229,9.08724,10.75229s3.02878-2.27135,5.7544-12.1151%20l19.82331-73.26013H99.08337c-1.06058-3.18081,0.45427-7.11812,2.27135-7.87554h14.23625%20c2.72562-8.7841,5.92356-17.60862,10.46719-25.63529c6.81497-12.26713,17.7193-21.95976,32.71205-21.95976%20c11.3586,0,16.05333,5.45216,16.05333,12.41917c-0.15111,7.42036-6.66293,11.20656-9.69263,11.20656%20c-2.42247,0-3.63416-1.81709-4.39159-4.39159c-2.57451-9.69263-5.90643-12.57029-7.87555-12.57029%20c-1.9682,0-4.99789,3.63416-8.3289,11.20656c-4.3925,9.54151-7.28729,19.72977-10.01291,29.72464h17.26501%20c1.05966,2.12023,0.15112,6.66385-2.42339,7.87554H132.24969z'/%3e%3c/g%3e%3c/svg%3e)
Key Decision Makers
Charlene Liao President